SYRASyra Health Corp

Nasdaq www.syrahealth.com


$ 2.16 $ 0.64 (42.67 %)    

Wednesday, 08-May-2024 15:58:27 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 2.14
$ 1.72
$ 0.00 x 0
$ 0.00 x 0
$ 1.72 - $ 2.16
$ 0.81 - $ 8.37
1,065,004
na
10.44M
$ 4.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 syra-health-bags-5-year-training-contract-from-sedgwick-county-health-department-in-kansas-to-combat-substance-use-disorder-financial-terms-undisclosed

Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a missio...

 syra-health-secures-statewide-healthcare-contract-in-missouri

Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company with a mission to improve healthcare by providing innovative s...

 syra-health-q4-eps-016-misses-009-estimate-sales-177m-miss-223m-estimate

Syra Health (NASDAQ:SYRA) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.09)...

 syra-health-expects-fy24-revenue-of-9m-11m-vs-1064m-est

2024 Financial Outlook The Company expects full-year 2024 revenue of $9 to $11 million, representing a growth of 64%-100% ve...

 syra-health-fy23-eps-060-vs-070-yoy-revenue-55m-vs-56m-yoy

2023 Financial Highlights2023 revenue of $5.5 million compared to $5.6 million in 2022.Business units excluding Healthcare Work...

 earnings-scheduled-for-march-25-2024

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

 us-health-agency-reviews-novo-nordisks-wegovy-for-potential-use-in-treating-heart-disease-patients-with-obesity

The CMS is reviewing the FDA's action to expand use of Wegovy to reduce the risk of cardiovascular death, heart attack and ...

 syra-health-secures-a-450000-contract-with-the-shelby-county-health-department-in-tennessee-to-bolster-the-countys-population-health-initiatives-two-additional-one-year-renewal-options-bringing-the-total-potential-value-of-the-contract-to-135m

Tennessee marks the 17th state Syra Health is now actively working inCARMEL, Ind., Feb. 27, 2024 /PRNewswire/ -- Syra Health Co...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION